RBC Capital Initiates Coverage On 10x Genomics with Sector Perform Rating, Announces Price Target of $70

Benzinga Newsdesk www.benzinga.com Positive 62.9%

Neg 0% Neu 0% Pos 62.9%

RBC Capital analyst Dan Leonard initiates coverage on 10x Genomics (NASDAQ:TXG) with a Sector Perform rating and announces Price Target of $70.